The Neurobiology of PTSD: Traumatic Memory Reconsolidation and the Persistence of Symptomatology

Post-Traumatic Stress Disorder (PTSD) represents a failure of the natural recovery process following exposure to life-threatening or overwhelming events. Although traumatic memories are expected to diminish in emotional intensity over time, contemporary research demonstrates that reactivated memories undergo a process known as reconsolidation, during which the memory trace temporarily destabilizes and becomes susceptible to modification. In PTSD, this reconsolidation process is disrupted: heightened noradrenergic activity, impaired hippocampal contextualization, and insufficient medial prefrontal regulatory control prevent adaptive updating of traumatic memories. Instead, retrieved memories become strengthened, maintaining their vivid, sensory, and emotionally intrusive characteristics. This article reviews the neurobiological foundations of traumatic memory persistence, examining the roles of the amygdala, hippocampus, and medial prefrontal cortex, as well as the neurochemical processes governing reconsolidation. By linking molecular mechanisms to clinical symptomatology—including intrusions, dissociation, and hypervigilance—this review highlights how maladaptive reconsolidation contributes to the chronicity of PTSD. Emerging pharmacological, psychotherapeutic, and neuromodulatory treatments are discussed in light of their ability to target reconsolidation or restore regulatory balance within fear and memory circuits. Understanding PTSD as a neurobiological disorder of memory persistence enables the development of interventions that not only reduce symptoms but potentially transform the underlying memory architecture.